Kronox Lab Sciences IPO Opening Soon: Check Allotment Details and More

2 Minutes Read
Kronox Lab Sciences IPO
Kronox Lab Sciences IPO Launching Soon | Representational Image: Unsplash

Summary

Kronox Lab Sciences IPO opens June 3, offering shares at Rs 129-136 each. Check allotment details and more. Apply by June 5.

Kronox Lab Sciences is launching its IPO next week on Monday (June 3, 2024), offering shares at a fixed price range of Rs 129 to Rs 136 each. Investors can apply till June 5, 2024.

Kronox Lab Sciences’ IPO involves its promoters, Joginder Singh Jaswal, Ketan Ramani, and Pritesh Ramani, and is fully an offer-for-sale (OFS) selling up to 95,70,000 equity shares valued at Rs 130.15 crore.

The company won’t receive any funds from the sale. Whereas, opening date for the anchor book is Friday, May 31.

Kronox Lab Sciences has set aside half of its IPO allocation for qualified institutional bidders (QIBs), with 15% reserved for non-institutional investors (NIIs). The remaining 35% is for retail investors.

Advertisement

Kronox specializes in the production of highly pure specialty chemicals with applications across various industries, including pharmaceuticals, scientific research, agriculture, and personal care. It also provides a large variety of more than 185 products, such as phosphate, sulphate, acetate, chloride, and others. It exports its offerings to more than 20 countries worldwide, including the USA, UK, Australia, Turkey, Argentina, Belgium, Mexico, China, United Arab Emirates, Egypt, and more.

Operating three manufacturing facilities and a Research, Development, and Testing (RDT) lab in Vadodara, Gujarat, situated near the seaports of Mundra, Kandla, Hazira, and Nhava Sheva. Kronox is expanding and planning a new manufacturing unit in Dahej.

Also Read: Study Abroad In Australia: Sydney University Student From Surat Shares Real Experience

The lead manager for the upcoming offer is Pantomath Capital Advisors Private Ltd. Whereas, the company plans to list its shares on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).

In the nine months till December 31, 2023, Kronox Labs earned a net profit of Rs 15.46 crore, generating revenue of Rs 68.44 crore, and total revenue was Rs 95.6 crore, showing a growth rate of 23.70% compared to FY2021.

Also Read: Piotex Industries IPO Opening on May 10: Key Details Here

The company achieved an EBITDA of Rs 22 crore, with an EBITDA margin of 23.01%. The profit after tax was Rs 16.6 crore.

Want to learn the art and science of managing your money? The 1% Club can help. Details here

Disclaimer: The above content is for informational purposes only. Please consult a SEBI-registered investment advisor before investing.

Share the Post:

Explore Money School

Explore Money School

Leave a Reply

Also read other articles

What is the difference between Claim Settlement Ratio and Incurred Claim Ratio in Health Insurance?

Claim Settlement Ratio and Incurred Claim Ratio are not same. And one of them do not apply to Health Insurance companies.

Income Tax Rebate U/S 87A Denied for Short-Term Capital Gains In New Tax Regime: Report

Taxpayers face denied Section 87A rebates on short-term capital gains after recent ITR utility update, conflicting with Income Tax Act.

All you need to know about Dixon Technologies, the company producing Google Pixel 8 in India

Dixon Technologies, founded in 1993 by Sunil Vachani, is a prominent contract manufacturer in India.

NITI Aayog’s Bold Vision for 2030: $500 Billion Electronics Production, 6 Million Jobs

NITI Aayog's report outlines a $500 billion electronics production target by 2030, aiming to create six million jobs.

Over 2 Lakh People Have Taken

Control of Their Financial Freedom

Financial Independence is the superpower
that can open a whole new world
of possibilities for you.

Join The 1% Club to know how it's done

Discover more from The 1% News

Subscribe now to keep reading and get access to the full archive.

Continue reading

Discover more from The 1% News

Subscribe now to keep reading and get access to the full archive.

Continue reading

Subscribe Now

Subscription Form